D.A. Thomas, NIDA-NIH (co-chair); R.G. Wiley, Vanderbilt University; W.J. Martin, UCSF; M.J. Iadorola, NIDCR-NIH; P. Mantyh, University of Minnesota; R.M. Caudle, University of Florida (co-chair)
A press conference was held prior to the Thursday, Oct. 28 symposium. Carl Hall, journalist for the San Francisco Chronicle, covered the issues well.
(You can view/print this article at: http://www.sfgate.com/cgi-bin/article.cgi?f=/chronicle/archive/1999/10/28/MN105769.DTL&type=printable)
The theme of the symposium centered on the Advanced Targeting Systems’ technology: targeting specific cell types using receptor internalization. For further details on this technology, check out the ATS tutorial.
Three of the four speakers, Dr. Ron Wiley, Dr. William Martin, and Dr. Pat Mantyh, presented stunning data utilizing products developed by Advanced Targeting Systems. The products covered were: anti-DBH-Saporin, 192-IgG-SAP, OX7-Saporin, Substance P-Saporin, and a conjugate using a more stable analog of Substance P, SSP-Saporin. All of these targeted toxins are currently available from ATS (see targeted toxins, for more information).